ProfileGDS4718 / 226941_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 87% 92% 87% 89% 88% 88% 89% 90% 87% 87% 88% 87% 92% 87% 88% 90% 89% 87% 84% 88% 89% 88% 88% 89% 91% 92% 91% 88% 92% 90% 90% 90% 86% 93% 92% 90% 89% 89% 93% 87% 90% 89% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6933886
GSM549102patient 115, normal, homogenized [OPG study]8.7489687
GSM549104patient 119, normal, homogenized [OPG study]9.6815792
GSM549108patient 138, normal, homogenized [OPG study]8.5950387
GSM549119patient 077, normal, homogenized [OPG study]9.0107389
GSM549133patient 032, cancer, homogenized [OPG study]8.9594988
GSM549139patient 042, cancer, homogenized [OPG study]8.9392988
GSM549099patient 107, normal, homogenized [OPG study]8.9774689
GSM549109patient 139, normal, homogenized [OPG study]9.1406290
GSM549110patient 046, normal, homogenized [OPG study]8.7905387
GSM549114patient 063, normal, homogenized [OPG study]8.9106187
GSM549122patient 082, normal, homogenized [OPG study]8.9128488
GSM549134patient 033, cancer, homogenized [OPG study]8.735487
GSM549136patient 036, cancer, homogenized [OPG study]9.5891492
GSM549140patient 044, cancer, homogenized [OPG study]8.8648387
GSM549111patient 047, normal, homogenized [OPG study]8.9519388
GSM549113patient 057, normal, homogenized [OPG study]9.4398890
GSM549132patient 031, cancer, homogenized [OPG study]9.0150389
GSM549137patient 038, cancer, homogenized [OPG study]8.6744687
GSM549142patient 047, cancer, homogenized [OPG study]7.9580484
GSM549100patient 110, normal, homogenized [OPG study]8.8620288
GSM549107patient 135, normal, homogenized [OPG study]9.0490189
GSM549115patient 068, normal, homogenized [OPG study]9.0423188
GSM549116patient 072, normal, homogenized [OPG study]8.9404788
GSM549120patient 078, normal, homogenized [OPG study]8.9664489
GSM549131patient 030, cancer, homogenized [OPG study]9.3758791
GSM549118patient 074, normal, homogenized [OPG study]9.543592
GSM549129patient 027, cancer, homogenized [OPG study]9.1744491
GSM549123patient 088, normal, homogenized [OPG study]8.9667788
GSM549124patient 006, cancer, homogenized [OPG study]9.4157192
GSM549126patient 015, cancer, homogenized [OPG study]9.135390
GSM549128patient 025, cancer, homogenized [OPG study]9.2589690
GSM549103patient 117, normal, homogenized [OPG study]9.0606590
GSM549117patient 073, normal, homogenized [OPG study]8.7577286
GSM549138patient 041, cancer, homogenized [OPG study]9.8049993
GSM549141patient 045, cancer, homogenized [OPG study]9.6506692
GSM549130patient 028, cancer, homogenized [OPG study]9.1091190
GSM549101patient 111, normal, homogenized [OPG study]8.9338889
GSM549105patient 128, normal, homogenized [OPG study]9.0174289
GSM549106patient 134, normal, homogenized [OPG study]9.8075793
GSM549112patient 048, normal, homogenized [OPG study]8.78987
GSM549125patient 011, cancer, homogenized [OPG study]9.1246390
GSM549127patient 024, cancer, homogenized [OPG study]8.9933789
GSM549135patient 035, cancer, homogenized [OPG study]8.598585